SkinBioTherapeutics plc

AIM:SBTX Stock Report

Market Cap: UK£36.3m

SkinBioTherapeutics Management

Management criteria checks 2/4

SkinBioTherapeutics' CEO is Stuart Ashman, appointed in Jul 2019, has a tenure of 5.33 years. total yearly compensation is £382.48K, comprised of 95.1% salary and 4.9% bonuses, including company stock and options. directly owns 0.12% of the company’s shares, worth £43.94K. The average tenure of the management team and the board of directors is 2 years and 5.5 years respectively.

Key information

Stuart Ashman

Chief executive officer

UK£382.5k

Total compensation

CEO salary percentage95.1%
CEO tenure5.3yrs
CEO ownership0.1%
Management average tenure2yrs
Board average tenure5.5yrs

Recent management updates

How Much Are SkinBioTherapeutics Plc (LON:SBTX) Insiders Taking Off The Table?

Jan 29
How Much Are SkinBioTherapeutics Plc (LON:SBTX) Insiders Taking Off The Table?

Recent updates

Here's Why We're Watching SkinBioTherapeutics' (LON:SBTX) Cash Burn Situation

Mar 28
Here's Why We're Watching SkinBioTherapeutics' (LON:SBTX) Cash Burn Situation

Will SkinBioTherapeutics (LON:SBTX) Spend Its Cash Wisely?

Sep 30
Will SkinBioTherapeutics (LON:SBTX) Spend Its Cash Wisely?

Is SkinBioTherapeutics (LON:SBTX) In A Good Position To Deliver On Growth Plans?

Jun 11
Is SkinBioTherapeutics (LON:SBTX) In A Good Position To Deliver On Growth Plans?

We Think SkinBioTherapeutics (LON:SBTX) Can Afford To Drive Business Growth

Feb 16
We Think SkinBioTherapeutics (LON:SBTX) Can Afford To Drive Business Growth

We're Not Worried About SkinBioTherapeutics' (LON:SBTX) Cash Burn

Sep 29
We're Not Worried About SkinBioTherapeutics' (LON:SBTX) Cash Burn

Companies Like SkinBioTherapeutics (LON:SBTX) Can Afford To Invest In Growth

Mar 23
Companies Like SkinBioTherapeutics (LON:SBTX) Can Afford To Invest In Growth

How Much Are SkinBioTherapeutics Plc (LON:SBTX) Insiders Taking Off The Table?

Jan 29
How Much Are SkinBioTherapeutics Plc (LON:SBTX) Insiders Taking Off The Table?

Companies Like SkinBioTherapeutics (LON:SBTX) Are In A Position To Invest In Growth

Dec 07
Companies Like SkinBioTherapeutics (LON:SBTX) Are In A Position To Invest In Growth

CEO Compensation Analysis

How has Stuart Ashman's remuneration changed compared to SkinBioTherapeutics's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2023n/an/a

-UK£3m

Sep 30 2023n/an/a

-UK£3m

Jun 30 2023UK£382kUK£364k

-UK£3m

Mar 31 2023n/an/a

-UK£3m

Dec 31 2022n/an/a

-UK£3m

Sep 30 2022n/an/a

-UK£3m

Jun 30 2022UK£368kUK£319k

-UK£3m

Mar 31 2022n/an/a

-UK£2m

Dec 31 2021n/an/a

-UK£2m

Sep 30 2021n/an/a

-UK£2m

Jun 30 2021UK£373kUK£323k

-UK£1m

Mar 31 2021n/an/a

-UK£1m

Dec 31 2020n/an/a

-UK£1m

Sep 30 2020n/an/a

-UK£1m

Jun 30 2020UK£276kUK£234k

-UK£2m

Mar 31 2020n/an/a

-UK£1m

Dec 31 2019n/an/a

-UK£1m

Sep 30 2019n/an/a

-UK£1m

Jun 30 2019UK£265kUK£52k

-UK£1m

Compensation vs Market: Stuart's total compensation ($USD479.78K) is above average for companies of similar size in the UK market ($USD354.57K).

Compensation vs Earnings: Stuart's compensation has increased whilst the company is unprofitable.


CEO

Stuart Ashman (58 yo)

5.3yrs

Tenure

UK£382,478

Compensation

Mr. Stuart John Ashman serves as Chief Executive Officer of SkinBioTherapeutics since July 2019 and serves as Executive Director at SkinBioTherapeutics Plc since April 18, 2019. Since 2014, he served as Ch...


Leadership Team

NamePositionTenureCompensationOwnership
Stuart Ashman
CEO & Executive Director5.3yrsUK£382.48k0.12%
£ 43.9k
Manprit Randhawa
CFO, Secretary & Director2.4yrsUK£261.48k0.067%
£ 24.3k
Laura Bey
Head of Formulations1.5yrsno datano data
Melissa Greenwell
Group Financial Controller1.7yrsno datano data

2.0yrs

Average Tenure

Experienced Management: SBTX's management team is considered experienced (2 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Stuart Ashman
CEO & Executive Director5.6yrsUK£382.48k0.12%
£ 43.9k
Manprit Randhawa
CFO, Secretary & Director2.4yrsUK£261.48k0.067%
£ 24.3k
Catherine Prescott
Independent Non-Executive Director7.7yrsUK£41.01k0.079%
£ 28.8k
Martin Hunt
Independent Non-Executive Chairman8.1yrsUK£68.67k0.25%
£ 89.0k
Catherine O'Neill
Scientific Adviser5.3yrsUK£66.42kno data
Danielle Bekker
Independent Non-Executive Director2.6yrsUK£25.00k0.019%
£ 6.9k

5.5yrs

Average Tenure

58yo

Average Age

Experienced Board: SBTX's board of directors are considered experienced (5.5 years average tenure).